APOA5 抗体 (FITC)
Quick Overview for APOA5 抗体 (FITC) (ABIN708708)
抗原
See all APOA5 抗体适用
宿主
克隆类型
标记
应用范围
-
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human APOA5
-
亚型
- IgG
-
-
-
-
应用备注
- IF(IHC-P)(1:50-200)
-
说明
-
Exitation/Emission: 494nm/518nm
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at 4°C
-
有效期
- 12 months
-
-
- APOA5 (Apolipoprotein A-V (APOA5))
-
别名
- Apolipoprotein A V
-
背景
-
Minor apolipoprotein mainly associated with HDL and to a lesser extent with VLDL. May also be associated with chylomicrons. Important determinant of plasma triglyceride (TG) levels by both being a potent stimulator of apo-CII lipoprotein lipase (LPL) TG hydrolysis and a inhibitor of the hepatic VLDL-TG production rate (without affecting the VLDL-apoB production rate) (By similarity). Activates poorly lecithin:cholesterol acyltransferase (LCAT) and does not enhance efflux of cholesterol from macrophages.
Subcellular location: Secreted
Synonyms: RAP3, APOAV, Apolipoprotein A-V, Apo-AV, ApoA-V, Apolipoprotein A5, Regeneration-associated protein 3, APOA5, UNQ411/PRO773 -
基因ID
- 116519
-
UniProt
- Q6Q788
-
途径
- Regulation of Lipid Metabolism by PPARalpha, Lipid Metabolism
抗原
-